- Home
- TONT vs VRXA Comparison
TONT vs VRXA Comparison
Compare TONT & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$1.15
Company Overview
Basic Information| Metric | TONT | VRXA |
|---|---|---|
| Founded | 2021 | 2021 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.5M | 141.4M |
| IPO Year | 2024 | 2025 |
Fundamental Metrics
Financial Performance| Metric | TONT | VRXA |
|---|---|---|
| Price | $10.96 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 132.6K | ★ 278.2K |
| Earning Date | 11-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.81 | $0.95 |
| 52 Week High | $10.96 | $4.50 |
Technical Indicators
Market Signals| Indicator | TONT | VRXA |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 50.03 |
| Support Level | $10.89 | $1.04 |
| Resistance Level | N/A | $1.41 |
| Average True Range (ATR) | 0.01 | 0.11 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 90.00 | 55.00 |
Price Performance
Historical Comparison TONT
VRXA
About TONT Graf Global Corp. Class A ordinary shares
Graf Global Corp is a blank check company.
About VRXA Veraxa Biotech AG Ordinary Shares
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.